Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (211-220 of 359) with videos related to

Pageof 36
Sort By:
Molecular Cancer Therapeutics|January 8, 2017
Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click ChemistryJacob L Houghton, Rosemery Membreno, Dalya Abdel-Atti, et al.
Molecular Pharmaceutics|May 1, 2014
Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternativesNerissa Therese Viola-Villegas, Kuntal K Sevak, Sean D Carlin, et al.
Journal of Neuro-Oncology|May 7, 2015
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapyKim Kramer, Neeta Pandit-Taskar, Pat Zanzonico, et al.
Molecular Imaging and Biology|April 20, 2019
The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional RadionuclidesL M Carter, Adam Leon Kesner, E C Pratt, et al.
Nuclear Medicine and Biology|May 14, 2020
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translationBrandon Nemieboka, Sai Kiran Sharma, Thapi Dharma Rao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 10, 2024
<sup>89</sup>Zr-immunoPET-guided selection of a CD33xIL15 fusion protein optimized for antitumor immune cell activation and in vivo tumour retention in acute myeloid leukaemiaNatalia Herrero Alvarez, Zaki Molvi, Kyle Lupo, et al.
Cancer Research|May 7, 2009
A novel technology for the imaging of acidic prostate tumors by positron emission tomographyAmy L Vāvere, Gráinne B Biddlecombe, William M Spees, et al.
Bioconjugate Chemistry|October 20, 2015
(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click ChemistryJan-Philip Meyer, Jacob L Houghton, Paul Kozlowski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2020
Comparison of <sup>68</sup>Ga-DOTA-JR11 PET/CT with dosimetric <sup>177</sup>Lu-satoreotide tetraxetan (<sup>177</sup>Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapySimone Krebs, Joseph A O'Donoghue, Evan Biegel, et al.
Nuclear Medicine and Biology|May 9, 2009
Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSHLihui Wei, Xiuli Zhang, Fabio Gallazzi, et al.
Pageof 36

Showing results (211-220 of 359) with videos related to

Sort By:
Pageof 36
Molecular Cancer Therapeutics|January 8, 2017
Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click ChemistryJacob L Houghton, Rosemery Membreno, Dalya Abdel-Atti, et al.
Molecular Pharmaceutics|May 1, 2014
Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternativesNerissa Therese Viola-Villegas, Kuntal K Sevak, Sean D Carlin, et al.
Journal of Neuro-Oncology|May 7, 2015
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapyKim Kramer, Neeta Pandit-Taskar, Pat Zanzonico, et al.
Molecular Imaging and Biology|April 20, 2019
The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional RadionuclidesL M Carter, Adam Leon Kesner, E C Pratt, et al.
Nuclear Medicine and Biology|May 14, 2020
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translationBrandon Nemieboka, Sai Kiran Sharma, Thapi Dharma Rao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 10, 2024
<sup>89</sup>Zr-immunoPET-guided selection of a CD33xIL15 fusion protein optimized for antitumor immune cell activation and in vivo tumour retention in acute myeloid leukaemiaNatalia Herrero Alvarez, Zaki Molvi, Kyle Lupo, et al.
Cancer Research|May 7, 2009
A novel technology for the imaging of acidic prostate tumors by positron emission tomographyAmy L Vāvere, Gráinne B Biddlecombe, William M Spees, et al.
Bioconjugate Chemistry|October 20, 2015
(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click ChemistryJan-Philip Meyer, Jacob L Houghton, Paul Kozlowski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2020
Comparison of <sup>68</sup>Ga-DOTA-JR11 PET/CT with dosimetric <sup>177</sup>Lu-satoreotide tetraxetan (<sup>177</sup>Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapySimone Krebs, Joseph A O'Donoghue, Evan Biegel, et al.
Nuclear Medicine and Biology|May 9, 2009
Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSHLihui Wei, Xiuli Zhang, Fabio Gallazzi, et al.
Pageof 36